<?xml version='1.0' encoding='utf-8'?>
<document id="20393255"><sentence text="Interaction between voriconazole and glimepiride."><entity charOffset="20-32" id="DDI-PubMed.20393255.s1.e0" text="voriconazole" /><entity charOffset="37-48" id="DDI-PubMed.20393255.s1.e1" text="glimepiride" /><pair ddi="false" e1="DDI-PubMed.20393255.s1.e0" e2="DDI-PubMed.20393255.s1.e0" /><pair ddi="false" e1="DDI-PubMed.20393255.s1.e0" e2="DDI-PubMed.20393255.s1.e1" /></sentence><sentence text="Voriconazole, a triazole antifungal, is gaining popularity in the treatment of invasive fungal infections, mostly in the immuno-compromised patients"><entity charOffset="0-12" id="DDI-PubMed.20393255.s2.e0" text="Voriconazole" /><entity charOffset="16-24" id="DDI-PubMed.20393255.s2.e1" text="triazole" /><pair ddi="false" e1="DDI-PubMed.20393255.s2.e0" e2="DDI-PubMed.20393255.s2.e0" /><pair ddi="false" e1="DDI-PubMed.20393255.s2.e0" e2="DDI-PubMed.20393255.s2.e1" /></sentence><sentence text=" Voriconazole, a CYP2C9 inhibitor, has many potential drug interactions"><entity charOffset="1-13" id="DDI-PubMed.20393255.s3.e0" text="Voriconazole" /></sentence><sentence text=" Its interactions are both due to its pharmacokinetic properties and the genetic polymorphism of CYP2C9 enzymes" /><sentence text=" Here is a case report of one such drug-drug interaction between voriconazole and glimepiride, an oral hypoglycemic agent, which led to prolonged and persistent hypoglycemia for 48 h"><entity charOffset="65-77" id="DDI-PubMed.20393255.s5.e0" text="voriconazole" /><entity charOffset="82-93" id="DDI-PubMed.20393255.s5.e1" text="glimepiride" /><pair ddi="false" e1="DDI-PubMed.20393255.s5.e0" e2="DDI-PubMed.20393255.s5.e0" /><pair ddi="false" e1="DDI-PubMed.20393255.s5.e0" e2="DDI-PubMed.20393255.s5.e1" /></sentence><sentence text=" It was diagnosed by the temporal association of the occurrence of symptoms with voriconazole intake"><entity charOffset="81-93" id="DDI-PubMed.20393255.s6.e0" text="voriconazole" /></sentence><sentence text=" The patient stabilized on withdrawal of the responsible drugs" /><sentence text=" Due to the high incidence of co-prescribing voriconazole with other drugs, caution has to be exercised while prescribing it"><entity charOffset="45-57" id="DDI-PubMed.20393255.s8.e0" text="voriconazole" /></sentence><sentence text=" Clinicians' awareness, a high index of suspicion and constant monitoring for adverse drug reactions, expected or unexpected drug interactions has to be emphasized, even if the co-prescribed drugs are in normal therapeutic doses" /><sentence text="" /></document>